-transparent.png){kind=logo}
1. NK1 and NK2 receptors have been characterized in guinea-pig lung membrane preparations by use of [125I-Tyr8]-substance P and [125I]-neurokinin A binding assays in conjunction with tachykinin-receptor selective agonists ([Sar9Met(O2)11]substance P for NK1 and [beta Ala8]neurokinin A (4-10) for NK2) and antagonists (CP-99,994 for NK1 and SR48968 for NK2). 2. The presence of high affinity, G-protein-coupled NK1 receptors in guinea-pig lung parenchymal membranes has been confirmed. The rank order of affinity for competing tachykinins was as predicted for an NK1 receptor: substance P = [Sar9Met(O2)11]substance P > substance P-methyl ester = physalaemin > neurokinin A = neurokinin B >> [beta Ala8]neurokinin A (4-10). The novel NK1 antagonist CP-99,994 has a Ki of 0.4 nM at this NK1 site. 3. In order to characterize [125I]-neurokinin A binding to guinea-pig lung, the number of [125I]-neurokinin A specific binding sites was increased 3-4 fold by purification of the parenchymal membranes over discontinuous sucrose gradients. The rank order of affinity determined for NK1- and NK2-receptor agonists and antagonists in competition for these sites showed that the majority (80%) of [125I]-neurokinin A specific binding was also to the NK1 receptor. 4. Under conditions where the guinea-pig lung parenchymal NK1 receptor was fully occupied by a saturating concentration of either [Sar9Met(O2)11]substance P (1 microM) or CP-99,994 (2.7 microM), residual [125I]-neurokinin A specific binding was inhibited in a concentration-dependent manner by both [beta Ala8]neurokinin A and SR48968. This result shows that the NK2 receptor is also present in these preparations. 5. Similar studies using guinea-pig tracheal membranes demonstrated that [125I]-neurokinin A specific binding was composed of a NK1-receptor component (60%), inhibited by both [Sar9Met(02)11]substance P and CP-99,994, and a significant NK2-receptor component, inhibited by both [beta Ala 8]neurokinin A andSR48968.6. In summary, these data demonstrate that guinea-pig lung parenchyma and guinea-pig trachea express both NK1 and NK2 receptors.
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
July 1990,
British journal of pharmacology,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
February 1993,
British journal of pharmacology,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
March 1994,
British journal of pharmacology,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
September 1996,
European journal of pharmacology,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
October 1993,
The American review of respiratory disease,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
September 1997,
Neuroscience,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
May 1994,
British journal of pharmacology,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
October 1993,
The American review of respiratory disease,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
January 1989,
Pulmonary pharmacology,
K T McKee, and
L Millar, and
I W Rodger, and
K M Metters
April 2001,
Regulatory peptides,
